The "House of Trust". A framework for quality healthcare and leadership.


Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2024
Historique:
accepted: 27 04 2024
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: epublish

Résumé

In healthcare, improvement leaders have been inspired by the frameworks from industry which have been adapted into control systems and certifications to improve quality of care for people. To address the challenge to regain trust in healthcare design and delivery, we propose a conceptual framework, i.e. the "House of Trust". This House brings together the Juran Trilogy, the emerging concept of co-production in quality management and the multidimensional definition of quality, which describes core values as an integral part of the system to deliver person- and kin-centered care. In the "House of Trust" patients, their kin, healthcare providers, executives and managers feel at home, with a sense of belonging. If we want to build a care organization that inspires and radiates confidence to all stakeholders, highlighting the basic interactions between front- and back-office is required. An organization with both well-organized back- and front-offices can enable all to benefit from the trust each of them needs and deserves. A quality system does not depend on government inspection and regulations nor on external accreditation to develop itself into a House of Trust. Success will only be achieved if all involved continuously question themselves about the technical dimensions of quality and their core values during the "moment of truth".

Identifiants

pubmed: 38881947
doi: 10.12688/f1000research.149711.1
pmc: PMC11179047
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

503

Investigateurs

Ann Baeyens (A)
Anneke Jans (A)
Astrid Van Wilder (A)
Brenda Droesbeke (B)
Dirk Vanrenterghem (D)
Els Van Zele (E)
Emanuel Van Hoecke (E)
Eva Marie Castro (EM)
Gerda Verheyden (G)
Ines Van Giel (I)
Ingrid Roosen (I)
Jef Vanderoost (J)
Jeroen Verhaeghe (J)
Karolien Pennewaert (K)
Kathleen De Sutter (K)
Koen Vanachter (K)
Kristin Muller (K)
Kristof Simoens (K)
Lieven Hoebrekx (L)
Mieke De Medts (M)
Nele Vanstraelen (N)
Nele Yperman (N)
Nina Donvil (N)
Sofie Wijnen (S)

Informations de copyright

Copyright: © 2024 Vanhaecht K et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Auteurs

Kris Vanhaecht (K)

Leuven Institute for Healthcare Policy, KU Leuven, KU Leuven University of Leuven, Leuven, Flanders, Belgium.
Department of Quality, University Hospitals of Leuven, Leuven, 3000, Belgium.

Peter Lachman (P)

Royal College of Physicians of Ireland, Dublin, Leinster, Ireland.

Charlotte Van der Auwera (C)

Leuven Institute for Healthcare Policy, KU Leuven, KU Leuven University of Leuven, Leuven, Flanders, Belgium.

Deborah Seys (D)

Leuven Institute for Healthcare Policy, KU Leuven, KU Leuven University of Leuven, Leuven, Flanders, Belgium.

Fien Claessens (F)

Leuven Institute for Healthcare Policy, KU Leuven, KU Leuven University of Leuven, Leuven, Flanders, Belgium.

Massimiliano Panella (M)

Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

Dirk De Ridder (D)

Leuven Institute for Healthcare Policy, KU Leuven, KU Leuven University of Leuven, Leuven, Flanders, Belgium.
Department of Quality, University Hospitals of Leuven, Leuven, 3000, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH